← Leaderboards
Edward M. Greenfield
Case Western Reserve University
$11,116,808
Attributed
$11,116,808
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $665K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,116,808 · 10
By mechanism
R01$6,773,112 · 6
T32$3,229,297 · 1
R21$1,114,399 · 3
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Peter Christopher Scacheri$11,607,442
- William Dean Pontius$186,002
- James Julius Morrow$182,272
- Ian Matthew Bayles$123,244
- Shunichi Murakami$1,318,742
Others in their field
Top investigators on “Osteoblasts”
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$29,617,439
- Clifford J Rosen · Icahn School Of Medicine At Mount Sinai$20,700,088
- Henry M Kronenberg · Massachusetts General Hospital$20,551,682
- Brendan Hl Lee · Baylor College Of Medicine$20,273,696
- Stavroula Kousteni · Columbia University Health Sciences$19,552,379
- Ernesto Canalis · University Of Connecticut Sch Of Med/Dnt$18,574,878
Research focus
OsteoblastsLaboratory MouseAffectOsteoclastsCell DifferentiationFutureMusculoskeletalCyclic AmpIn VivoMediatingOsteoporosisSignal TransductionRegulationTraining ProgramsBoneResponsePharmaceutical PreparationsOsteocalcinCell LineGeneticLeadIn VitroCyclic Amp-Dependent Protein KinasesMesenchyme
Grant awards (39)
Regulation of age-related bone loss by PKIgamma$419,487
R01 · FY2024 · AG · contact PI
Regulation of age-related bone loss by PKIgamma$416,879
R01 · FY2023 · AG · contact PI
Regulation of age-related bone loss by PKIgamma$414,226
R01 · FY2022 · AG · contact PI
Regulation of age-related bone loss by PKIgamma$410,995
R01 · FY2021 · AG · contact PI
Regulation of age-related bone loss by PKIgamma$419,737
R01 · FY2020 · AG · contact PI
P2X7R: A Novel Therapeutic Target in Implant Loosening$131,555
R21 · FY2018 · AR · contact PI
P2X7R: a novel therapeutic target in implant loosening$74,065
R21 · FY2018 · AR · contact PI
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases$206,843
R21 · FY2017 · CA · contact PI
P2X7R: a novel therapeutic target in implant loosening$167,218
R21 · FY2017 · AR · contact PI
Training Program in Musculoskeletal Research$373,057
T32 · FY2016 · AR · contact PI
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases$172,369
R21 · FY2016 · CA · contact PI
Training Program in Musculoskeletal Research$363,159
T32 · FY2015 · AR · contact PI
Training Program in Musculoskeletal Research$275,754
T32 · FY2014 · AR · contact PI
Training Program in Musculoskeletal Research$300,933
T32 · FY2013 · AR · contact PI
ERK Mitogen Activated Protein Kinases in Skeletogenesis$335,729
R01 · FY2012 · AR · contact PI
Training Program in Musculoskeletal Research$329,313
T32 · FY2012 · AR · contact PI
ERK Mitogen Activated Protein Kinases in Skeletogenesis$335,729
R01 · FY2011 · AR · contact PI
Training Program in Musculoskeletal Research$328,578
T32 · FY2011 · AR · contact PI
Training Program in Musculoskeletal Research$325,565
T32 · FY2010 · AR · contact PI
Training Program in Musculoskeletal Research$314,613
T32 · FY2009 · AR · contact PI
Training Program in Musculoskeletal Research$265,650
T32 · FY2008 · AR · contact PI
IN VIVO REGULATION OF cAMP/PKA SIGNALING BY PKIgamma$163,044
R21 · FY2008 · AR · contact PI
Training Program in Musculoskeletal Research$352,675
T32 · FY2007 · AR · contact PI
IN VIVO REGULATION OF cAMP/PKA SIGNALING BY PKIgamma$199,305
R21 · FY2007 · AR · contact PI
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS$276,399
R01 · FY2006 · DK · contact PI
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS$283,052
R01 · FY2005 · DK
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS$219,555
R01 · FY2005 · AR
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS$283,052
R01 · FY2004 · DK
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS$251,685
R01 · FY2004 · AR
TERMINATION OF PTH RESPONSES IN OSTEOBLASTS$362,610
R01 · FY2003 · DK
CELLULAR MECHANISMS OF IMPLANT LOOSENING$267,750
R01 · FY2003 · AR
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS$251,685
R01 · FY2003 · AR
CELLULAR MECHANISMS OF IMPLANT LOOSENING$267,750
R01 · FY2002 · AR
CYTOKINES AND REGULATION OF BONE TURNOVER BY PTH$264,156
R01 · FY2002 · AR
OSTEOCLAST DIFFERENTIATION BY MESENCHYMAL CELLS$251,685
R01 · FY2002 · AR
CELLULAR MECHANISMS OF IMPLANT LOOSENING$267,750
R01 · FY2001 · AR
CYTOKINES AND REGULATION OF BONE TURNOVER BY PTH$256,462
R01 · FY2001 · AR
CELLULAR MECHANISMS OF IMPLANT LOOSENING$267,750
R01 · FY2000 · AR
CYTOKINES AND REGULATION OF BONE TURNOVER BY PTH$248,989
R01 · FY2000 · AR